ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

News Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:09 13/06/2025 pm IST			5-day change	1st Jan Change
0.8400 ^HKD	-3.45%		+3.70%	-15.15%

10/04	Zhongzhi Pharmaceutical Holdings Limited Announces Board and Committee Changes, Effective 10 April 2025	CI
26/03	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Zhongzhi Pharmaceutical Holdings Limited Approves Dividend	13/05	CI
Zhongzhi Pharmaceutical Holdings Limited Announces Board and Committee Changes, Effective 10 April 2025	10/04	CI
Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2024, Payable on 19 June 2025	26/03	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	26/03	CI
Zhongzhi Pharmaceutical Expects Profit to Plunge 45% in 2024	17/01	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2024	17/01	CI
Zhongzhi Pharmaceutical Invests in US Biotech Firm to Advance Alzheimer's Treatment	24/12	MT
Zhongzhi Pharmaceutical Holdings Plans to Unwind Contractual Agreements to Directly Hold Control Over Subsidiary	06/12	MT
Zhongzhi Pharmaceutical Holdings Limited Announces Resignation of Peng Zhiyun as Non-Executive Director	09/24/09	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	23/24/23	CI
Zhongzhi Pharmaceutical Warns of 40% Drop in H1 Profit	12/24/12	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2024	12/24/12	CI
Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend	17/24/17	CI
Zhongzhi Pharmaceutical's Attributable Jumps in 2023	25/24/25	MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 13 June 2024	22/24/22	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	22/24/22	CI
Zhongzhi Pharmaceutical Expects Over 50% Surge in 2023 Profit	26/24/26	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	25/24/25	CI
Zhongzhi Pharmaceutical Holdings Limited Approves Interim Dividend	13/23/13	CI
Zhongzhi Pharmaceutical’s Profit Up 75% in H1	24/23/24	MT
Zhongzhi Pharmaceutical Holdings Limited Proposes Interim Dividend for the Six Months Ended 30 June 2023, Payable on 2 November 2023	23/23/23	CI
Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
Zhongzhi Pharmaceutical Expects 70% Increase in H1 Profit; Shares Jump 7%	20/23/20	MT
Zhongzhi Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023	19/23/19	CI
Zhongzhi Pharmaceutical Unit Chooses Builder for New Factory	23/23/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Filters